A threat to decentralised care for drug-resistant tuberculosis. (2020)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(20)30392-1
PubMed Identifier: 33007284
Publication URI: http://europepmc.org/abstract/MED/33007284
Type: Journal Article/Review
Volume: 8
Parent Publication: The Lancet. Respiratory medicine
Issue: 10
ISSN: 2213-2600